NVIDIA enters the second week of July in an unusual position — the stock has held its ground while most of its semiconductor peers have not, and the question that matters now is whether that relative resilience reflects genuine conviction or simply delayed re-pricing.
The peer divergence is striking. AMD fell 6.5% on Tuesday alone, down 4.3% on the week. AMKR dropped more than 20% over the same period. POET shed 16%. RMBS lost 14.5%. NVIDIA, by contrast, closed at $196.93 — down just 1.6% on the week and up 0.7% on Tuesday. For a stock that spent most of June absorbing a geopolitical discount and a product-roadmap controversy, holding the $192–$200 channel while the sector sells off around it is a meaningful data point. Whether it reflects NVIDIA's specific AI infrastructure story or simply slower price discovery is harder to say.
The lending market refuses to tell a bearish story. Short interest remains at just 1.2% of the free float — 293.6 million shares — down fractionally on the week and down 0.3% on the month. Borrow availability is essentially unlimited; the pool is so deep it doesn't register meaningful constraint. Cost to borrow has eased another 9.6% on the week to 0.20%, which is at the lower end of its 30-day range. None of this resembles a market where professional short sellers are building a case. Options positioning is similarly relaxed — the put/call ratio is 0.82, a touch below its 20-day average of 0.86, and 0.6 standard deviations below that mean. The 52-week low on the PCR was 0.70; the current reading is nowhere near defensively elevated territory. Positioning, in short, looks indifferent to the downside.
The Street's structure hasn't shifted materially, though the most recent analyst data runs to late June. The consensus remains firmly constructive, with the mean price target near $302 — implying roughly 53% upside from current levels. Most of that target concentration reflects post-earnings upgrades from late May, when firms including Evercore ISI and Tigress Financial lifted targets sharply into the $350–$425 range. The more cautious end of the Street — Needham and RBC both holding targets at $270 — still sits well above the current print. The bull case rests on NVIDIA's full-stack AI platform dominance and sustained cloud-provider GPU demand. Bears point to rising competition in the data center and the risk that enterprise AI adoption proves slower than consensus expects. The valuation has compressed alongside the price: the forward P/E has declined roughly 2.2 turns on the month to 18.5x, and EV/EBITDA has come in about 0.8 turns to 15.1x. That is not cheap in absolute terms, but it is meaningfully lower than where the stock traded entering June.
The ORTEX short score has edged up slightly over the past two weeks — from 28.9 on June 24 to 29.1 today — but the move is negligible and the score remains in low-squeeze territory. More telling is the momentum picture highlighted in this week's stock-score analysis: the 91-day relative strength reading has fallen from roughly 205 in mid-June to just 21, a sharp deterioration that stands in contrast to AMD and Intel, both of which now show rising relative strength above 1,700 even as they sell off in price. NVIDIA leads its peer group decisively on quality metrics — a Piotroski F-score of 8, ROA of 57.7% — but the momentum pillar is where the score currently drags.
The next hard catalyst is the August 19 earnings print. The prior three results have each produced negative first-day reactions, ranging from -0.5% to -3.6%, with five-day moves equally soft. The $192–$200 range that absorbed the Kyber delay story and the DeepSeek chip headlines last week now becomes the reference frame: what breaks it, and from which direction, is the setup worth monitoring into results season.
See the live data behind this article on ORTEX.
Open NVDA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
